1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide

C158H228N22O19 — CID 159324058

IUPAC1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide
SMILESCCC(=O)CN1CC2(CCC(c3ccccc3)(N(C)C)CC2)N(CC2CCC2)C1=O.CN(C)C1(c2ccccc2)CCC2(CC1)CN(CC(=O)CCCO)C(=O)N2CC1CCC1.CN(C)C1(c2ccccc2)CCC2(CC1)CN(CC(=O)Cc1cccc(=O)[nH]1)C(=O)N2CC1CCC1.COCCN1C(=O)N(CC(=O)CCC(N)=O)CC12CCC(c1ccccc1)(N(C)C)CC2.COCCN1C(=O)N(CC(=O)CCCO)CC12CCC(c1ccccc1)(N(C)C)CC2.COc1ncc(CCC(=O)CN2CC3(CCC(c4ccccc4)(N(C)C)CC3)N(CC3CCC3)C2=O)cn1
InChIInChI=1S/C30H41N5O3.C29H38N4O3.C26H39N3O3.C25H37N3O2.C24H36N4O4.C24H37N3O4/c1-33(2)30(25-10-5-4-6-11-25)16-14-29(15-17-30)22-34(28(37)35(29)20-23-8-7-9-23)21-26(36)13-12-24-18-31-27(38-3)32-19-24;1-31(2)29(23-10-4-3-5-11-23)16-14-28(15-17-29)21-32(27(36)33(28)19-22-8-6-9-22)20-25(34)18-24-12-7-13-26(35)30-24;1-27(2)26(22-10-4-3-5-11-22)15-13-25(14-16-26)20-28(19-23(31)12-7-17-30)24(32)29(25)18-21-8-6-9-21;1-4-22(29)18-27-19-24(28(23(27)30)17-20-9-8-10-20)13-15-25(16-14-24,26(2)3)21-11-6-5-7-12-21;1-26(2)24(19-7-5-4-6-8-19)13-11-23(12-14-24)18-27(17-20(29)9-10-21(25)30)22(31)28(23)15-16-32-3;1-25(2)24(20-8-5-4-6-9-20)13-11-23(12-14-24)19-26(18-21(29)10-7-16-28)22(30)27(23)15-17-31-3/h4-6,10-11,18-19,23H,7-9,12-17,20-22H2,1-3H3;3-5,7,10-13,22H,6,8-9,14-21H2,1-2H3,(H,30,35);3-5,10-11,21,30H,6-9,12-20H2,1-2H3;5-7,11-12,20H,4,8-10,13-19H2,1-3H3;4-8H,9-18H2,1-3H3,(H2,25,30);4-6,8-9,28H,7,10-19H2,1-3H3
InChIKeyLEDBLASAIZLGFY-UHFFFAOYSA-N
MW2739.70 g/mol
LogP20.45
Rot. Bonds54

About 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide

1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide (PubChem CID 159324058) has the molecular formula C158H228N22O19 and a molecular weight of 2739.70 g/mol. Its IUPAC name is 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide.

Molecular Properties

Compound Name1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide
PubChem CID159324058
Molecular FormulaC158H228N22O19
Molecular Weight2739.70 g/mol
Exact Mass2737.76
IUPAC Name1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide
SMILESCCC(=O)CN1CC2(CCC(c3ccccc3)(N(C)C)CC2)N(CC2CCC2)C1=O.CN(C)C1(c2ccccc2)CCC2(CC1)CN(CC(=O)CCCO)C(=O)N2CC1CCC1.CN(C)C1(c2ccccc2)CCC2(CC1)CN(CC(=O)Cc1cccc(=O)[nH]1)C(=O)N2CC1CCC1.COCCN1C(=O)N(CC(=O)CCC(N)=O)CC12CCC(c1ccccc1)(N(C)C)CC2.COCCN1C(=O)N(CC(=O)CCCO)CC12CCC(c1ccccc1)(N(C)C)CC2.COc1ncc(CCC(=O)CN2CC3(CCC(c4ccccc4)(N(C)C)CC3)N(CC3CCC3)C2=O)cn1
InChIInChI=1S/C30H41N5O3.C29H38N4O3.C26H39N3O3.C25H37N3O2.C24H36N4O4.C24H37N3O4/c1-33(2)30(25-10-5-4-6-11-25)16-14-29(15-17-30)22-34(28(37)35(29)20-23-8-7-9-23)21-26(36)13-12-24-18-31-27(38-3)32-19-24;1-31(2)29(23-10-4-3-5-11-23)16-14-28(15-17-29)21-32(27(36)33(28)19-22-8-6-9-22)20-25(34)18-24-12-7-13-26(35)30-24;1-27(2)26(22-10-4-3-5-11-22)15-13-25(14-16-26)20-28(19-23(31)12-7-17-30)24(32)29(25)18-21-8-6-9-21;1-4-22(29)18-27-19-24(28(23(27)30)17-20-9-8-10-20)13-15-25(16-14-24,26(2)3)21-11-6-5-7-12-21;1-26(2)24(19-7-5-4-6-8-19)13-11-23(12-14-24)18-27(17-20(29)9-10-21(25)30)22(31)28(23)15-16-32-3;1-25(2)24(20-8-5-4-6-9-20)13-11-23(12-14-24)19-26(18-21(29)10-7-16-28)22(30)27(23)15-17-31-3/h4-6,10-11,18-19,23H,7-9,12-17,20-22H2,1-3H3;3-5,7,10-13,22H,6,8-9,14-21H2,1-2H3,(H,30,35);3-5,10-11,21,30H,6-9,12-20H2,1-2H3;5-7,11-12,20H,4,8-10,13-19H2,1-3H3;4-8H,9-18H2,1-3H3,(H2,25,30);4-6,8-9,28H,7,10-19H2,1-3H3
InChIKeyLEDBLASAIZLGFY-UHFFFAOYSA-N
XLogP20.45
TPSA433.04 Ų
H-Bond Donors4
H-Bond Acceptors27
Rotatable Bonds54
Heavy Atoms199
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002739.70
LogP ≤ 520.45
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1027

Analyze 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide?
The IUPAC name of 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide (CID 159324058) is 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide.
What is the SMILES notation for 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide?
The canonical SMILES for 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide is CCC(=O)CN1CC2(CCC(c3ccccc3)(N(C)C)CC2)N(CC2CCC2)C1=O.CN(C)C1(c2ccccc2)CCC2(CC1)CN(CC(=O)CCCO)C(=O)N2CC1CCC1.CN(C)C1(c2ccccc2)CCC2(CC1)CN(CC(=O)Cc1cccc(=O)[nH]1)C(=O)N2CC1CCC1.COCCN1C(=O)N(CC(=O)CCC(N)=O)CC12CCC(c1ccccc1)(N(C)C)CC2.COCCN1C(=O)N(CC(=O)CCCO)CC12CCC(c1ccccc1)(N(C)C)CC2.COc1ncc(CCC(=O)CN2CC3(CCC(c4ccccc4)(N(C)C)CC3)N(CC3CCC3)C2=O)cn1.
What is the InChIKey of 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide?
The InChIKey is LEDBLASAIZLGFY-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H41N5O3.C29H38N4O3.C26H39N3O3.C25H37N3O2.C24H36N4O4.C24H37N3O4/c1-33(2)30(25-10-5-4-6-11-25)16-14-29(15-17-30)22-34(28(37)35(29)20-23-8-7-9-23)21-26(36)13-12-24-18-31-27(38-3)32-19-24;1-31(2)29(23-10-4-3-5-11-23)16-14-28(15-17-29)21-32(27(36)33(28)19-22-8-6-9-22)20-25(34)18-24-12-7-13-26(35)30-24;1-27(2)26(22-10-4-3-5-11-22)15-13-25(14-16-26)20-28(19-23(31)12-7-17-30)24(32)29(25)18-21-8-6-9-21;1-4-22(29)18-27-19-24(28(23(27)30)17-20-9-8-10-20)13-15-25(16-14-24,26(2)3)21-11-6-5-7-12-21;1-26(2)24(19-7-5-4-6-8-19)13-11-23(12-14-24)18-27(17-20(29)9-10-21(25)30)22(31)28(23)15-16-32-3;1-25(2)24(20-8-5-4-6-9-20)13-11-23(12-14-24)19-26(18-21(29)10-7-16-28)22(30)27(23)15-17-31-3/h4-6,10-11,18-19,23H,7-9,12-17,20-22H2,1-3H3;3-5,7,10-13,22H,6,8-9,14-21H2,1-2H3,(H,30,35);3-5,10-11,21,30H,6-9,12-20H2,1-2H3;5-7,11-12,20H,4,8-10,13-19H2,1-3H3;4-8H,9-18H2,1-3H3,(H2,25,30);4-6,8-9,28H,7,10-19H2,1-3H3.
What are the key properties of 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide?
1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide has a molecular weight of 2739.70 g/mol, XLogP of 20.45, 54 rotatable bonds, 4 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(cyclobutylmethyl)-8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[4-(2-methoxypyrimidin-5-yl)-2-oxobutyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-(2-oxobutyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;1-(cyclobutylmethyl)-8-(dimethylamino)-3-[2-oxo-3-(6-oxo-1H-pyridin-2-yl)propyl]-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-3-(5-hydroxy-2-oxopentyl)-1-(2-methoxyethyl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;5-[8-(dimethylamino)-1-(2-methoxyethyl)-2-oxo-8-phenyl-1,3-diazaspiro[4.5]decan-3-yl]-4-oxopentanamide is sourced from PubChem (CID 159324058), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).